NCT02423187已完成不适用
Rabeprazole Specific Clinical Experience Investigation for the Long-term Combination Therapy With Low-dose Aspirin
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 1,568
- 主要终点
- Incidence of adverse drug reactions
研究概览
简要总结
To investigate the safety and efficacy of long-term combination therapy with rabeprazole and low-dose aspirin.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
结局指标
主要结局
Incidence of adverse drug reactions
时间窗: 52 weeks
次要结局
- Recurrence rate of peptic ulcer(52 weeks)
研究者
相似试验
已完成
3 期
Comparing the Efficacy, Safety, and Tolerability of Rabeprazole ER 50 mg With Placebo in Subjects With Symptomatic Gastroesophageal Reflux Disease (sGERD)Symptomatic Gastroesophageal Reflux Disease (sGERD)NCT00911534Eisai Inc.305
未知
Unknown
Rabeprazole specific clinical experience investigation for the long-term combination therapy with low-dose aspiriGastric ulcer, Duodenal ulcerJPRN-jRCT1080222833Eisai Co., Ltd.1,400
已完成
3 期
Open Label Study Evaluating Different Dosing Regimens of Rabeprazole in Gastro-esophageal Reflux Disease (GERD) Patients With Night-time Heartburn Symptoms.HeartburnGastroesophageal RefluxNCT00553449Janssen-Ortho Inc., Canada48
已完成
3 期
A Study of the Safety and Effectiveness of Rabeprazole for the Treatment of Gastroesophageal Reflux Disease (GERD) in Pediatric PatientsGastroesophageal Reflux Disease (GERD)NCT00787891Johnson & Johnson Pharmaceutical Research & Development, L.L.C.127
已完成
2 期
A Study of E3810 for Japanese Subjects With Functional Dyspepsia (SAMURAI Study: Suppression of Acid Milieu With Rabeprazole Improving Functional Dyspepsia ) (Study E3810-J081-204)Functional DyspepsiaNCT01089543Eisai Co., Ltd.338